Andrew Bogdan

This inventor holds 19 USPTO granted patents and 26 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Cystic Fibrosis Treatment. Top assignees: Galapagos Nv, Abbvie S.a.r.l., Abbvie Inc.. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Bogdan. Retrieved from https://idiyas.com/inventor/andrew-bogdan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 26)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 13)

EPO Patents = 12 (Patent Applications = 24)

Average Co-Inventor Count = 11.1

ph-index = 4

Forward Citations = 110(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...

Areas of Expertise:

Cystic Fibrosis

Bromodomain Inhibitors

Heteroaryl Compounds

Pyridines

Pyrrolidines

Tricyclics

Chromanes

Triazadibenzo

Methods of Use

Protein Modulators

Carboxamides

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-27),

2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-20),

3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-10),

6. 10604515 - Heteroaryl substituted pyridines and methods of use (2020-03-31),

7. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2019-10-01),

8. 10399940 - Substituted pyrrolidines and methods of use (2019-09-03),

9. 10138227 - Heteroaryl substituted pyridines and methods of use (2018-11-27),

10. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein (2018-11-06),

11. 10085985 - Bromodomain inhibitors (2018-10-02),

12. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors (2018-07-31),

13. 9981910 - Substituted pyrrolidines and methods of use (2018-05-29),

14. 9969693 - 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use (2018-05-15),

15. 9840513 - Substituted tricyclics and method of use (2017-12-12),

Title: The Innovative Journey of Andrew Bogdan

Introduction: Andrew Bogdan, a talented inventor based in Evanston, IL (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Andrew Bogdan's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: Throughout his illustrious career, Andrew Bogdan has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have not only improved the lives of many but have also paved the way for future advancements in various industries.

Collaborations: Andrew Bogdan has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Andrew Bogdan stands as a shining example of an inventor who is not afraid to think outside the box and challenge the status quo. His passion for innovation continues to drive him towards creating solutions that have a lasting impact on society.

Profile summary based on public USPTO records.